REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Chong Kun Dang Pharmaceutical Corp. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chong Kun Dang Pharmaceutical Corp. Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Chong Kun Dang Pharmaceutical Corp. is engaged in manufacturing and selling of medicines. The company offers products such as prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, anticancer, and immunosuppressant; health supplements, including prebiotics complex Prelacto and Premium Omega-3+vitamin; and healthy beverage products. In addition, Chong Kun Dang Pharmaceutical Corp. also provides over-the-counter drugs, such as Penzal for headache; Zelcom for antithelmintic; Prefemine for premenstrual syndrome. The company was founded in 2013 and is headquartered in Seoul, South Korea.

Headquarters
Chongkundang Bldg 368, Chungjeongno 3-Ga, Seodaemun-Gu
Seoul; Seoul; Postal Code: 120 756

Contact Details: Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.

Website: http://www.ckdpharm.com

Basic Information
Total Employees:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Outstanding Shares:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Registered Capital:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Financial Auditors:
Purchase the Chong Kun Dang Pharmaceutical Corp. report to view the information.
Incorporation Date:
November 05, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
25.4%
Purchase this report to view the information.
13.4%
Subsidiaries
Chongkundang Holdings Corp.
Ckd Bio Corp.
Kyongbo Pharmaceutical Co. Ltd.
Company Performance
Financial values in the chart are available after Chong Kun Dang Pharmaceutical Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.38%▼
Total operating revenue
-0.34%▼
Operating profit (EBIT)
-14.05%▼
EBITDA
-10.44%▼
Net Profit (Loss) for the Period
3.1%▲
Total assets
23.86%▲
Total equity
27.65%▲
Operating Profit Margin (ROS)
-1.39%▼
Net Profit Margin
0.37%▲
Return on Equity (ROE)
-2.22%▼
Debt to Equity Ratio
-9.93%▼
Quick Ratio
0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo